SCHEMBL9036103

SCHEMBL9036103

CCCCCn1c(C(F)F)c(CCC(C)C)n(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)c1=O

nearest known ligand 0.43

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 10/20 0.43
AGTR2 P50052 10/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9035872 0.98 AGTR1 (0.42) AGTR1AGTR2
SCHEMBL9036264 0.94 AGTR1 (0.40) AGTR1AGTR2
SCHEMBL9035467 0.94 AGTR1 (0.45) AGTR1AGTR2
SCHEMBL9036643 0.94 AGTR1 (0.47) AGTR1AGTR2
SCHEMBL9035952 0.93 AGTR1 (0.43) AGTR1AGTR2
SCHEMBL9036564 0.93 AGTR1 (0.36) AGTR1AGTR2
SCHEMBL9036939 0.91 AGTR1 (0.39) AGTR1AGTR2
SCHEMBL9035027 0.91 AGTR1 (0.46) AGTR1AGTR2
SCHEMBL9036452 0.91 AGTR1 (0.44) AGTR1AGTR2
SCHEMBL9533457 0.91 AGTR1 (0.38) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0555331-B1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS SEARLE & CO (US) 1996-04-24 EP claimed
EP-0555331-B1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS SEARLE & CO (US) 1996-04-24 EP disclosed
US-5238952-A Treating glaucoma disorders G. D. SEARLE & CO. (US) 1993-08-24 US disclosed
US-5087634-A N-substituted imidazol-2-one compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1992-02-11 US disclosed